Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 91Breast Neoplasms 21Insulin Resistance 18Obesity 14Prostatic Neoplasms 10Pancreatic Neoplasms 8Endometrial Neoplasms 7Neoplasms 6Infertility 6Anovulation 6Neoplasm Metastasis 5Colorectal Neoplasms 5Rectal Neoplasms 4Hyperandrogenism 4Weight Loss 3Squamous Cell Carcinoma of Head and Neck 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lung Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hyperinsulinism 3Head and Neck Neoplasms 3Diabetes Mellitus, Type 2 3Diabetes Mellitus 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Recurrence 2Rare Diseases 2Premature Birth 2Overweight 2Ovarian Neoplasms 2

Interventions

Rosuvastatin Calcium 1Metformin 1Digoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Drug-drug Interaction,SHR3680 × Metformin × Clear all
NCT04621669 2026-06-05

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
36 enrolled

Drug-drug Interaction,SHR3680

Data powered by HemOnc (CC BY 4.0) Colophon âš¡